These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24394867)

  • 41. Hand coordination as a quantitative measure of motor abnormality and therapeutic response in Parkinson's disease.
    Benice TS; Lou JS; Eaton R; Nutt J
    Clin Neurophysiol; 2007 Aug; 118(8):1776-84. PubMed ID: 17576094
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pattern of subclinical pulmonary dysfunctions in Parkinson's disease and the effect of levodopa.
    Pal PK; Sathyaprabha TN; Tuhina P; Thennarasu K
    Mov Disord; 2007 Feb; 22(3):420-4. PubMed ID: 17230476
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Salivary production in Parkinson's disease.
    Proulx M; de Courval FP; Wiseman MA; Panisset M
    Mov Disord; 2005 Feb; 20(2):204-7. PubMed ID: 15389996
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa.
    Hauser RA; Rascol O; Korczyn AD; Jon Stoessl A; Watts RL; Poewe W; De Deyn PP; Lang AE
    Mov Disord; 2007 Dec; 22(16):2409-17. PubMed ID: 17894339
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Daily motor performance after switching levodopa to melevodopa: an open-label on advanced Parkinson's disease with "delayed-on" and/or"wearing-off".
    Bosco D; Plastino M; Bosco F; Fava A; Rotondo A
    Minerva Med; 2011 Apr; 102(2):125-32. PubMed ID: 21483399
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Levodopa-carbidopa intestinal gel for treatment of advanced Parkinson's disease.
    Fernandez HH; Odin P
    Curr Med Res Opin; 2011 May; 27(5):907-19. PubMed ID: 21351823
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma levodopa peak delay and impaired gastric emptying in Parkinson's disease.
    Doi H; Sakakibara R; Sato M; Masaka T; Kishi M; Tateno A; Tateno F; Tsuyusaki Y; Takahashi O
    J Neurol Sci; 2012 Aug; 319(1-2):86-8. PubMed ID: 22632782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of levodopa on the habituation of the acoustic-palpebral reflex in Parkinson's disease.
    Rey RD; Garretto NS; Bueri JA; Simonetti DD; Sanz OP; Sica RE
    Electromyogr Clin Neurophysiol; 1996 Sep; 36(6):357-60. PubMed ID: 8891475
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Levodopa improves time-based prospective memory in Parkinson's disease.
    Costa A; Peppe A; Brusa L; Caltagirone C; Gatto I; Carlesimo GA
    J Int Neuropsychol Soc; 2008 Jul; 14(4):601-10. PubMed ID: 18577289
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Levodopa challenge test and (123) I-metaiodobenzylguanidine scintigraphy for diagnosing Parkinson's disease.
    Asayama S; Wate R; Kaneko S; Asayama T; Oki M; Tsuge A; Nagashima M; Morita J; Nakamura S; Nakamura M; Nishii M; Fujita K; Saito A; Nakano S; Ito H; Kusaka H
    Acta Neurol Scand; 2013 Sep; 128(3):160-5. PubMed ID: 23410225
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of levodopa treatment in the voice pattern of Parkinson's disease patients: a systematic review and meta-analysis.
    Pinho P; Monteiro L; Soares MFP; Tourinho L; Melo A; Nóbrega AC
    Codas; 2018 Oct; 30(5):e20170200. PubMed ID: 30304100
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Levodopa ameliorated anorectal constipation in de novo Parkinson's disease: The QL-GAT study.
    Tateno F; Sakakibara R; Yokoi Y; Kishi M; Ogawa E; Uchiyama T; Yamamoto T; Yamanishi T; Takahashi O
    Parkinsonism Relat Disord; 2011 Nov; 17(9):662-6. PubMed ID: 21705259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease.
    Herzog J; Möller B; Witt K; Pinsker MO; Deuschl G; Volkmann J
    Mov Disord; 2009 Jun; 24(8):1206-10. PubMed ID: 19412937
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Voice quality severity and responsiveness to levodopa in Parkinson's disease.
    Cushnie-Sparrow D; Adams S; Abeyesekera A; Pieterman M; Gilmore G; Jog M
    J Commun Disord; 2018; 76():1-10. PubMed ID: 30053648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phonatory characteristics of parkinsonian speech before and after morning medication: the ON and OFF states.
    Goberman A; Coelho C; Robb M
    J Commun Disord; 2002; 35(3):217-39. PubMed ID: 12064785
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Off and on state assessment of swallowing function in Parkinson's disease.
    Warnecke T; Hamacher C; Oelenberg S; Dziewas R
    Parkinsonism Relat Disord; 2014 Sep; 20(9):1033-4. PubMed ID: 24997546
    [No Abstract]   [Full Text] [Related]  

  • 57. [Acoustic analysis of prosody in females with Parkinson's disease: comparison with normal controls].
    Azevedo LL; Cardoso F; Reis C
    Arq Neuropsiquiatr; 2003 Dec; 61(4):999-1003. PubMed ID: 14762606
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Voice Quality and Orofacial Strength as Outcome of Levodopa Effectiveness in Patients with Early Idiopathic Parkinson Disease: A Preliminary Report.
    Lechien JR; Blecic S; Ghosez Y; Huet K; Harmegnies B; Saussez S
    J Voice; 2019 Sep; 33(5):716-720. PubMed ID: 29724466
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Abdominal pain: a symptom of levodopa end of dose wearing off in Parkinson's disease.
    Rana AQ; Depradine J
    West Indian Med J; 2011 Mar; 60(2):223-4. PubMed ID: 21942133
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Voice onset time in Parkinson disease.
    Fischer E; Goberman AM
    J Commun Disord; 2010; 43(1):21-34. PubMed ID: 19717164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.